about
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.MiRNAs as new master players.Resistance to targeted therapies: a role for microRNAs?Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells.Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization.YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC.MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling.A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI TraitsPotential role of two novel agonists of thyroid hormone receptor-β on liver regeneration
P50
Q33942266-F5884D74-1A16-40A1-A6C6-7FA705F85A0DQ37555902-874E3DC8-2809-43A9-9F51-674FEB5EC6F8Q38135075-661EA681-E12B-4F30-832B-DFF5D029D5B0Q38421322-FFE7C5AD-DA0A-4E12-ABF4-DC2D52A8D85AQ38751892-44999931-CA4C-4D52-AFA7-9FB056AE3AB5Q38929781-8D6B7A07-05A8-4107-9FA4-E502408D88DFQ43632068-402FF897-BA28-4766-9177-83116431D0D3Q48001908-35842D73-218F-48A0-B8CF-D6CCC03D6BDDQ52638232-892C15B5-AAEB-4D9F-BC6B-E8D83C569308Q64961076-9ED0D3C3-5AD9-43C0-9F24-3D3249C22261Q90493756-1242CE91-46DF-4E93-A6AD-FA58A839F2E5Q94455992-DB684715-3D49-48ED-85F0-2F5054452446
P50
description
investigador
@es
researcher
@en
name
Cristina Migliore
@en
type
label
Cristina Migliore
@en
prefLabel
Cristina Migliore
@en
P31
P496
0000-0003-3722-2814